SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 163 filers reported holding SYNDAX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $68,471 | +128.2% | 3,242 | +162.7% | 0.02% | +46.7% |
| Q3 2022 | $30,000 | +36.4% | 1,234 | +9.0% | 0.02% | +7.1% |
| Q2 2022 | $22,000 | -78.6% | 1,132 | -80.9% | 0.01% | -73.1% |
| Q1 2022 | $103,000 | +171.1% | 5,933 | +238.6% | 0.05% | +188.9% |
| Q4 2021 | $38,000 | +26.7% | 1,752 | +10.9% | 0.02% | -5.3% |
| Q3 2021 | $30,000 | +150.0% | 1,580 | +122.8% | 0.02% | +137.5% |
| Q2 2021 | $12,000 | – | 709 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,932,800 | $33,592,000 | 10.90% |
| Aisling Capital Management LP | 1,025,000 | $17,815,000 | 9.61% |
| Frazier Life Sciences Management, L.P. | 3,195,403 | $55,536,000 | 4.73% |
| Paradigm Biocapital Advisors LP | 701,356 | $12,190,000 | 3.22% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,277,413 | $22,201,000 | 3.14% |
| Nantahala Capital Management | 2,692,303 | $46,792,000 | 2.07% |
| Avidity Partners Management LP | 4,823,400 | $83,831,000 | 1.75% |
| DAFNA Capital Management LLC | 371,987 | $6,465,000 | 1.68% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,582,000 | 1.67% |
| BVF INC/IL | 2,394,714 | $41,620,000 | 1.66% |